2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Vitiligo in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wan, J | 1 |
| Lin, F | 1 |
| Zhang, W | 1 |
| Xu, A | 1 |
| DeGiorgis, J | 1 |
| Lu, H | 1 |
| Wan, Y | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Vitiligo
| Article | Year |
|---|---|
Novel approaches to vitiligo treatment via modulation of mTOR and NF-κB pathways in human skin melanocytes.
Topics: alpha-MSH; Blotting, Western; Cells, Cultured; Chromones; Humans; Hydrogen Peroxide; Melanocytes; Mi | 2017 |